Veracyte: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Tuesday reported a loss of $1.9 million in its first quarter.

The South San Francisco, California-based company said it had a loss of 2 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The molecular diagnostic company posted revenue of $96.8 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $93.8 million.

Veracyte expects full-year revenue in the range of $402 million to $410 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on VCYT at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up